Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intraperitoneal photodynamic therapy.

K A Cengel1, E Glatstein, S M Hahn

  • 1Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

Cancer Treatment and Research
|July 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is there a role for salvage radiotherapy in locally advanced breast cancer refractory to neoadjuvant chemotherapy?

Breast (Edinburgh, Scotland)·2016
Same author

Proton pencil beam scanning for mediastinal lymphoma: the impact of interplay between target motion and beam scanning.

Physics in medicine and biology·2015
Same author

Acute hematological effects of solar particle event proton radiation in the porcine model.

Radiation research·2013
Same author

External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2012
Same author

TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions.

Bone marrow transplantation·2010
Same author

Comparative gene expression analysis of avian embryonic facial structures reveals new candidates for human craniofacial disorders.

Human molecular genetics·2009
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Intraperitoneal photodynamic therapy (PDT) shows promise for peritoneal carcinomatosis, but early trials reveal toxicity. Future research focuses on targeted photosensitizers and nanotechnology to improve efficacy and safety.

Area of Science:

  • Oncology
  • Photodynamic Therapy

Background:

  • Peritoneal carcinomatosis and sarcomatosis lack effective treatments.
  • Intraperitoneal photodynamic therapy (PDT) offers a superficial treatment approach for peritoneal carcinomatosis.

Purpose of the Study:

  • To evaluate the clinical activity and toxicity of first-generation intraperitoneal PDT using Photofrin for peritoneal carcinomatosis.
  • To explore the therapeutic index and identify limitations of current intraperitoneal PDT.

Main Methods:

  • A Phase II clinical trial involving intraperitoneal PDT with Photofrin.
  • Correlative studies assessing photosensitizer uptake in human tumor and normal tissues.

Main Results:

  • Intraperitoneal PDT was clinically tolerable but exhibited significant toxicity, indicating a narrow therapeutic index.

Related Experiment Videos

  • Clinical activity was observed in heavily pre-treated patients, suggesting treatment efficacy.
  • Photosensitizer uptake showed limited selectivity for tumors over normal tissues, contributing to toxicity.

    • Conclusions:

    • Lack of photosensitizer selectivity and tumor hypoxia limit the therapeutic index of current intraperitoneal PDT.
    • Novel targeted photosensitizers, growth factor signaling inhibition, and nanotechnology-based fractionated PDT hold potential to improve efficacy and safety.
    • Future advancements may enable well-tolerated and effective treatments for intraperitoneal carcinomatosis using PDT.